The prevalence of side effect of Risperidone drug in patient with schizophrenia
Phase 3
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT201011225147N2
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
the diagnosis of schizophrenia by a psychiatrist based on DSMIV-TR criteria, age 15 – 60 years, no history of use of any other drug over 6 months prior to the study, no history of any other systemic diseases such as epilepsy, hematological diseases, CVD, glaucoma
Exclusion criteria: poor cooperation, not coming for visits, incidence of serious side effects
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse effects. Timepoint: two times: 15 days and 30 days after intervention. Method of measurement: Visiting by psychiatrist based on interview, mental status examination,filling questionnaire.
- Secondary Outcome Measures
Name Time Method